TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for LOR
check button Gene summary
Basic gene informationGene symbolLOR
Gene nameloricrin
Synonyms-
CytomapUCSC genome browser: 1q21
Type of geneprotein-coding
RefGenesNM_000427.2,
Description-
Modification date20141207
dbXrefs MIM : 152445
HGNC : HGNC
Ensembl : ENSG00000203782
HPRD : 01070
Vega : OTTHUMG00000013938
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_LOR
BioGPS: 4014
PathwayNCI Pathway Interaction Database: LOR
KEGG: LOR
REACTOME: LOR
Pathway Commons: LOR
ContextiHOP: LOR
ligand binding site mutation search in PubMed: LOR
UCL Cancer Institute: LOR
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesHPA,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Skin
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)SKCM
Reference showing the relevant tissue of LOR
Description by TissGene annotations
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID
GO:0018149peptide cross-linking10908733
GO:0030216keratinocyte differentiation10908733
GO:0018149peptide cross-linking10908733
GO:0030216keratinocyte differentiation10908733


Top
TissGeneExp for LOR

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
LUSC-0.702914389-1.8364241931.1335098043.93E-058.46E-05


Top
TissGene-miRNA for LOR

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for LOR
TissGeneSNV for LOR

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.S152LESCA1
p.W309LLUAD1
p.G127CACC1
p.G282VSARC1
p.A306VLIHC1
p.P310LCOAD1
p.G278ESKCM1
p.Y189CKIRP1
p.T301ASKCM1
p.G22SLUAD1
p.V295ISTAD1
p.S91FCOAD1
p.G31DSTAD1
p.S235CLIHC1


Top
TissGeneCNV for LOR

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for LOR

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for LOR

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (tumor)LOR, SP1, FOS, IVL, CREB1, KRT1, ATF1, EVPL, SP3, CSTA, VIM, PI3, SPRR3 (normal)
bullet pointbullet point


Top
TissGeneProg for LOR

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for LOR
TissGeneDrug for LOR

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for LOR

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C1858805Vohwinkel Syndrome, Variant Form9BeFree,CLINVAR,CTD_human,ORPHANET
umls:C0011615Dermatitis, Atopic7BeFree,GAD,LHGDN
umls:C0013595Eczema5BeFree
umls:C0022579Keratoderma4BeFree
umls:C0022596Palmoplantar Keratosis4BeFree
umls:C0033860Psoriasis4BeFree
umls:C0334166Pseudoainhum4BeFree
umls:C0020757Ichthyoses3BeFree
umls:C0020758Congenital ichthyosis3BeFree
umls:C0432330Erythrokeratoderma3BeFree
umls:C1832097EPIDERMAL DIFFERENTIATION COMPLEX3BeFree
umls:C0007137Squamous cell carcinoma2BeFree,CTD_human
umls:C0023493Adult T-Cell Lymphoma/Leukemia2BeFree
umls:C0037274Dermatologic disorders2BeFree
umls:C0265964Mutilating keratoderma2BeFree
umls:C0008312Primary biliary cirrhosis1BeFree
umls:C0023531Leukoplakia1BeFree
umls:C0027627Neoplasm Metastasis1BeFree
umls:C0029172Oral Submucous Fibrosis1BeFree
umls:C0037268Skin Abnormalities1BeFree
umls:C0037286Skin Neoplasms1CTD_human
umls:C0079583Ichthyosiform Erythroderma, Congenital1BeFree
umls:C0079773Lymphoma, T-Cell, Cutaneous1BeFree
umls:C0265961Erythrokeratodermia variabilis1BeFree
umls:C0278488Carcinoma breast stage IV1BeFree
umls:C0870082Hyperkeratosis1BeFree